Skip to main content
. 2018 Nov 29;25:101060. doi: 10.1016/j.redox.2018.11.018

Fig. S4.

Fig. S4

A) Disease-free survival analysis for DNAJC18high vs DNAJC18low patients in the esophageal carcinoma dataset. B) Overall survival analysis for CCT6Ahigh vs CCT6Alow patients in the oesophageal carcinoma dataset.